Influence of genetic polymorphisms in CYP1A2, CYP2C19, CYP3A4, GSTP1, MDR1 and PSMB5 genes in toxicity and response to induction therapy in multiple myeloma patients included in the trial of the Spanish PETHEMA/GEM 05 for newly diagnosed MM elderly patien
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2011Título de revista
Blood
Tipo de contenido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)